Abstract
Vanadium is a trace element that has raised increasing interest in diabetology since the discovery of its insulin-like properties in vitro and in vivo. This brief article reviews the most recent data concerning the beneficial effects of vanadium compounds on fuel homeostasis in animal models of insulinopenic (Type I) or insulin-resistant (Type II) diabetes. These studies open obvious therapeutic possibilities in diabetes, and more particularly, in states of insulin resistance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brichard SM, Lederer J, Henquin JC: The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes? Diabete Metab 17: 435 440, 1991
Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474–1477, 1985
Meyerovitch J, Farfel Z, Sack J, Shechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J Biol Chem 262: 6658–6662, 1987
Gil J, Miralpeix M, Carreras J, Bartrons R: Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem 263: 1868–1871, 1988
Brichard SM, Okitolonda W, Henquin JC: Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048–2053, 1988
Blondel O, Bailbe D, Portha B: In vivo insulin resistance in streptozotocin-diabetic rats — evidence for reversal following oral vanadate treatment. Diabetologia 32: 185–190, 1989
Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH: Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904–H911, 1989
Pugazhenthi S, Khandelwal RL: Insulinlike effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats. Diabetes 39: 821–827, 1990
Venkatesan N, AvidanA, Davidson MB: Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity. Diabetes 40: 492–498, 1991
Malabu UH, Dryden S, McCarthy HD, Kilpatrick A, Williams G: Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attribuable entirely to its suppression of feeding. Diabetes 43: 9–15, 1994
Henquin JC, Carton F, Ongemba LN, Becker DJ: Improvement of mild hypoinsulinaemic diabetes in the rat by low doses of vanadium. J Endocrinol 142: 555–561, 1994
Granner D, Pilkis S: The genes of hepatic glucose metabolism. J Biol Chem 265: 10173–10176, 1990
Brichard SM, Desbuquois B, Girard J: Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2. Mol Cell Endocrinol 91: 91–97, 1993
Valera A, Rodriguez-Gil JE, Bosch F: Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats. J Clin Invest 92: 4–11, 1993
Miralpeix M, Carballo E, Bartrons RI, Crepin K, Hue L, Rousseau GG: Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA. Diabetologia 35: 243–248, 1992
Brichard SM, Henquin JC, Girard J: Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia 36: 292–298, 1993
Miralpeix M, Decaux JF, Kahn A, Bartrons R: Vanadate induction of L-type pyruvate kinase mRNA in adult rat hepatocytes in primary cultures. Diabetes 40: 462–464, 1991
Bosch F, Hatzoglou M, Park EA, Hanson RW: Vanadate inhibits expression of the gene for phosphoenolpyruvate carboxykinase (GTP) in rat hepatoma cells. J Biol Chem 265: 13677–13682, 1990
Brichard SM, Ongemba LN, Girard J, Henquin JC: Tissue-specific correction of lipogenic enzyme gene expression in diabetic rats given vanadate. Diabetologia 37: 1065–1072, 1994
Foufelle F, Gouhot B, Pegorier JP, Perdereau D, Girard J, Ferre P: Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue. A role for glucose 6-phosphate. J Biol Chem 267: 20543–20546, 1992
Iritani N: Nutritional and hormonal regulation of lipogenic-enzyme gene expression in rat liver. Eur J Biochem 205: 433–442, 1992
Rossetti L, Laughlin MR: Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84: 892–899, 1989
Strout HV, Vicario PP, Biswas C, Saperstein R, Brady EJ, Pilch PF, Berger J: Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin responsive glucose transporter in skeletal muscle. Endocrinology 126: 2728–2732, 1990
Brichard SM, Pottier AM, Henquin JC: Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 125: 2510–2516, 1989
Brichard SM, Bailey CJ, Henquin JC: Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes 39: 1326–1332, 1990
Meyerovitch J, Rothenberg P, Shechter Y, Bonner-Weir S, Kahn CR: Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. J Clin Invest 87: 1286–1294, 1991
Pugazhenthi S, Angel JF, Khandelwal RL: Long-term effects of vanadate on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice. Metabolism 40: 941–946, 1991
Brichard SM, Ongemba LN, Kolanowski J, Henquin JC: The influence of vanadate on insulin counter-regulatory hormones in obese fa/fa rats. J Endocrinol 131: 185–191, 1991
Brichard SM, Assimacopoulos-Jeannet F, Jeanrenaud B: Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression. Endocrinology 131: 311–317, 1992
Brichard SM, Ongemba LN, Henquin JC: Oral vanadate decreases muscle insulin resistance in obese fa/fa rats. Diabetologia 35: 522–527, 1992
Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248: E353–E362, 1985
Morgan HE, Cadenas E, Regen DM, Park CR: Regulation of glucose uptake in muscle. II. Rate limiting steps and effect. J Biol Chem 236: 262–268, 1961
Friedman JE, Sherman WN, Reed MJ, Elton CW, Dohm GL: Exercise training increases glucose transporter protein GLUT4 in skeletal muscle of obese Zucker (fa/fa) rats. FEBS Lett 268: 13–16, 1990
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Kluwer Academic Publishers
About this chapter
Cite this chapter
Brichard, S.M. (1995). Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes. In: Srivastava, A.K., Chiasson, JL. (eds) Vanadium Compounds: Biochemical and Therapeutic Applications. Developments in Molecular and Cellular Biochemistry, vol 16. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1251-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1251-2_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8533-5
Online ISBN: 978-1-4613-1251-2
eBook Packages: Springer Book Archive